Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 3:2018:1286170.
doi: 10.1155/2018/1286170. eCollection 2018.

A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid Levels

Affiliations

A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid Levels

Subrata Deb et al. Int J Hepatol. .

Abstract

Background: To examine the association between low-density lipoprotein (LDL) and high-density lipoprotein (HDL) levels and liver enzyme functions.

Methods: The National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2012 was used to examine the association between liver enzymes and lipid levels amongst adults in the United States.

Results: Sixteen percent adults had ALT > 40 U/L, 11% had AST > 40 U/L, and 96% had ALP > 120 U/L. Age, gender, and race/ethnicity showed significant association with LDL, HDL, and triglycerides levels. LDL greater than borderline high was associated with little over two times higher odds of elevated ALT (OR: 2.33, 95% CI: 2.17, 2.53, p ≤ 0.001) and AST (OR: 2.79, 95% CI: 2.55, 3.06, p ≤ 0.001). High HDL was associated with 50% higher odds for elevated ALT (OR: 1.51, 95% CI: 1.39, 1.64, p ≤ 0.001) and over two-and-half fold elevated AST (OR: 2.77, 95% CI: 2.47, 3.11, p ≤ 0.001). LDL-C, HDL-C, and triglycerides were found to be good predictor of elevated ALT, AST, and ALP levels. Similarly, old age and female gender were significant predictor of elevated ALT and AST (p ≤ 0.001).

Conclusions: Underlying hepatic pathophysiology from dyslipidemia deserves further exploration due to its potential effects on hepatic drug metabolism/detoxification.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Badimon L., Vilahur G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos. Annals of the New York Academy of Sciences. 2012;1254(1):18–32. doi: 10.1111/j.1749-6632.2012.06480.x. - DOI - PubMed
    1. Ahmed M. Non-alcoholic fatty liver disease in 2015. World Journal of Hepatology. 2015;7(11):1450–1459. doi: 10.4254/wjh.v7.i11.1450. - DOI - PMC - PubMed
    1. Nelson R. H. Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Primary Care—Clinics in Office Practice. 2013;40(1):195–211. doi: 10.1016/j.pop.2012.11.003. - DOI - PMC - PubMed
    1. Giannini E. G., Testa R., Savarino V. Liver enzyme alteration: a guide for clinicians. Canadian Medical Association Journal. 2005;172(3):367–379. doi: 10.1503/cmaj.1040752. - DOI - PMC - PubMed
    1. National Health and Nutrition Examination Survey (NHANES), National Center for Health Statistics. Hyattsville, MD; Center for Disease Control and Prevention, U.S. Department of Health and Human Services. https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx, 2017.

LinkOut - more resources